ASX ANNOUNCEMENT 11 October 2016 BOARD CHANGES Sydney, Australia - QRxPharma Limited (ASX: QRX and OTC Pink Current: QRXPY) announces the following changes to its Board of Directors.

Mr John Rainbow having consented to act has been appointed to the Board effective 11 October 2016. John has been a legal practitioner for over 25 years in NSW and during his career has actively contributed at a senior board level and as in-house legal counsel.

Mr Tim Heesh having consented to act has been appointed to the Board effective 11 October 2016. Tim is a member of the Chartered Accountants in Australia and New Zealand and the Australian Restructuring, Insolvency and Turnaround Association.

John Rainbow and Tim Heesh will be seeking shareholder approval for their appointment at the Company's 2016 Annual General Meeting next month.

Mr Bruce Hancox and Dr Richard Treagus having been elected as Non-Executive Directors by shareholders in July 2014 have resigned their positions with immediate effect.

Following a period of Voluntary Administration the creditors of the Company voted in favour of a Deed of Company Arrangement (DOCA), which was wholly effectuated on 23 December 2015, thereby returning the management and control of the Company to the Board.

Mr Bruce Hancox commented; "We warmly welcome John and Tim to the Board of QRx Pharma and we are confident that given their broad corporate expertise they are extremely well suited to focus on the compliance matters that may enable the reinstatement of the Company's securities to official quotation on the Australian Securities Exchange (ASX).

###

Cameron Jones Company Secretary 03 9092 0475

QRxpharma Ltd. published this content on 11 October 2016 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 11 October 2016 06:01:04 UTC.

Original documenthttp://www.qrxpharma.com/irm/PDF/1526/ChangeinBoardComposition

Public permalinkhttp://www.publicnow.com/view/25FBA1D8212E80573C32565ED6357A591F7A29D4